Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.53)
# 865
Out of 5,152 analysts
97
Total ratings
40%
Success rate
9.04%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $72 → $25 | $7.58 | +229.82% | 3 | Mar 4, 2026 | |
| CLYM Climb Bio | Initiates: Overweight | $23 | $7.31 | +214.64% | 1 | Feb 13, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $11.15 | +169.06% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $325.11 | +269.11% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $4.73 | +217.12% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $21.07 | +246.46% | 1 | Jan 27, 2026 | |
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.74 | +1,336.78% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $434.80 | +106.99% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $34.99 | +114.35% | 1 | Dec 18, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.86 | +265.11% | 5 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $24.40 | +219.67% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $11.95 | +67.36% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $6.02 | +331.89% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $4 | $1.29 | +210.08% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $4.02 | +1,840.30% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $38.13 | +280.28% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $28.88 | +76.59% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.63 | +268.10% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $18.36 | +161.44% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $79.31 | +17.26% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $7.80 | +861.54% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $71.11 | +47.66% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $31.18 | +18.67% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $6.99 | +271.96% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $1.17 | +2,293.16% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $39.51 | +145.51% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $27.41 | +177.27% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $4.27 | +485.48% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $10.91 | +174.98% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $10.37 | +15.72% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $7.07 | +1,172.98% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.58 | +2,486.21% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.62 | +184.70% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $60.55 | +32.12% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $63.13 | +47.32% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $27.08 | +110.49% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.76 | +1,063.19% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.96 | +1,973.61% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $94.83 | -63.09% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $15.41 | +464.57% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $6.86 | +2,451.02% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $62.27 | +15.63% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $14.00 | +257.14% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.58 | +6,779.94% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.76 | +2,268.42% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $14.54 | +2,788.58% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $93.04 | -17.24% | 1 | Jul 31, 2020 |
Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Overweight
Price Target: $72 → $25
Current: $7.58
Upside: +229.82%
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $7.31
Upside: +214.64%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $11.15
Upside: +169.06%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $325.11
Upside: +269.11%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $4.73
Upside: +217.12%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $21.07
Upside: +246.46%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.74
Upside: +1,336.78%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $434.80
Upside: +106.99%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $34.99
Upside: +114.35%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.86
Upside: +265.11%
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $24.40
Upside: +219.67%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $11.95
Upside: +67.36%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $6.02
Upside: +331.89%
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.29
Upside: +210.08%
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $4.02
Upside: +1,840.30%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $38.13
Upside: +280.28%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $28.88
Upside: +76.59%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.63
Upside: +268.10%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $18.36
Upside: +161.44%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $79.31
Upside: +17.26%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $7.80
Upside: +861.54%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $71.11
Upside: +47.66%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $31.18
Upside: +18.67%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $6.99
Upside: +271.96%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.17
Upside: +2,293.16%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $39.51
Upside: +145.51%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $27.41
Upside: +177.27%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $4.27
Upside: +485.48%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $10.91
Upside: +174.98%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $10.37
Upside: +15.72%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $7.07
Upside: +1,172.98%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.58
Upside: +2,486.21%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.62
Upside: +184.70%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $60.55
Upside: +32.12%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $63.13
Upside: +47.32%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $27.08
Upside: +110.49%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.76
Upside: +1,063.19%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.96
Upside: +1,973.61%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $94.83
Upside: -63.09%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $15.41
Upside: +464.57%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $6.86
Upside: +2,451.02%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $62.27
Upside: +15.63%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $14.00
Upside: +257.14%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.58
Upside: +6,779.94%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.76
Upside: +2,268.42%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $14.54
Upside: +2,788.58%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $93.04
Upside: -17.24%